ArticleBMC medical imaging2025
Application of CT-based radiomics combined with laboratory tests such as AFP and PIVKA-II in preoperative prediction of pathologic grade of hepatocellular carcinoma.
Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Indeterminate nodule-like arterial phase hyperenhancement in the liver on CT: differentiation of hepatocellular carcinomas from vascular pseudolesions using a CT radiomics approach.Journal of gastrointestinal oncology · 2026Article
- Protein Induced by Vitamin K Absence or Antagonist II in Primary Liver Cancer: Basic Research Insights and Clinical Applications.Journal of clinical and translational hepatology · 2025Review
- Multiparametric magnetic resonance imaging of deep learning-based super-resolution reconstruction for predicting histopathologic grade in hepatocellular carcinoma.World journal of gastroenterology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundTo investigate how effectively clinical features and CT-based radiomic features predict the pathological grade of hepatocellular carcinoma (HCC).
methodsWe retrospectively analyzed 108 patients diagnosed with hepatocellular carcinoma who underwent pathological examination between May 2020 and May 2024 at the Second Hospital of Jilin University. All patients underwent laboratory tests and contrast-enhanced computed tomography (CECT) scanning of the liver within one month prior to pathological examination. First, we analyzed laboratory tests, such as alpha fetoprotein (AFP) and des-γ-carboxy prothrombin (PIVKA-II), to identify risk factors associated with the pathological grading of HCC. Then, we built and evaluated the performance of the clinical model. Next, we imported the arterial-phase and venous-phase images of the CECT images into the uAI Research Portal research platform for 'one-stop' processing, which included semiautomatic ROI outlining, feature extraction, dimensionality reduction, model construction and evaluation. To evaluate the model's diagnostic effectiveness, receiver operating characteristic (ROC) curves were produced, and the related accuracy, sensitivity, specificity, and area under the curve (AUC) were computed. The models were compared using the Delong test, and the clinical value of the predictive model was assessed via the use of calibration curves and decision curve analysis (DCA) to quantify the agreement between the model and the actual outcomes.
resultsPoorly differentiated hepatocellular carcinoma (pHCC) is associated with risk variables such as hepatitis C virus antibodies(HCVAb), PIVKA-II, and sex. In the training and validation cohorts, the AUC values of the clinical model were 0.719 and 0.692, respectively; those of the AP model were 0.843 and 0.773; those of the VP model were 0.806 and 0.804; those of the AP + VP model were 0.953 and 0.844; and those of the AP + VP + clinical model were 0.926 (95% CI: 0.88-0.995) and 0.863 (95% CI: 0.711-1). The DCA curves revealed that the overall net benefit of the AP + VP + clinical model was greater than that of the other models and that it had the best diagnostic results.
conclusionsCT-based radiomic modeling combined with clinical features (sex) and laboratory tests (e.g., AFP and PIVKA-II) can reliably predict the pathological grade of HCC patients prior to surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.